Brought to you by:
Multidisciplinary approach to diabetic foot ulcers in rural America leads to NIH grant
Samantha Minc, MD, MPH, associate professor of surgery at Duke University, has been awarded a National Institutes of Health (NIH) R03 grant to support her research project, “Understanding diabetes and peripheral arterial disease [PAD]-related amputation in North Carolina.” The R03…
Updated intermittent claudication guidelines reflect a decade of new evidence
The Society for Vascular Surgery (SVS) recently published comprehensive update to its clinical practice guidelines (CPGs) for the management of intermittent claudication (IC), urging clinicians to prioritize conservative treatment strategies and patient-centered care. The new recommendations, which appeared in the…
SVS Highway to Health campaign aims to make PAD a household term
The Society for Vascular Surgery (SVS) is ramping up its national Highway to Health campaign to educate the public about peripheral arterial disease (PAD) and the importance of early detection as part of September’s PAD Awareness Month. Anahita Dua, MD,…
Enduring PROMISE: Real-world outcomes study suggests results continue to flow from transcatheter arterialization of the deep veins
First retrospective analysis shows comparable outcomes data to those found in PROMISE II pivotal trial, authors report. The first post-approval multicenter analysis of so-called “no-option” chronic limb-threatening ischemia (CLTI) patients treated using a pioneering transcatheter arterialization of the deep veins…
Advances in endovascular therapy help drive innovative CPVI training course
The SVS Complex Peripheral Vascular Interventions (CPVI) Skills Course has become a fixture on the vascular surgery calendar over the past couple of years. Here, course director Vipul Khetarpaul, MD, gives Marlén Gomez the rundown on how the evolution of…
Start of PAD Awareness Month heralds joint national effort to prevent amputations
The PAD Pulse Alliance—a coalition of leading medical societies that includes the Society for Vascular Surgery (SVS) dedicated to improving vascular health—is urging patients, providers and policymakers to act through its Get a Pulse on PAD Campaign as national PAD…
SWEDEPAD re-opens paclitaxel safety discussion, finds drug-coated devices do not improve outcomes
Drug-coated balloons and stents were not associated with reduced risk of amputation or improved quality of life compared with uncoated devices in the SWEDEPAD 1 and 2 trials. In addition, higher five-year mortality with drug-coated devices in patients with intermittent…
Pharmacologic treatment, follow-up in cessation services help drive abstinence in PAD patients
A recent French study suggests smoking cessation in patients with peripheral arterial disease (PAD) is achievable with intensive and appropriate management, with the prescription of a pharmacologic smoking cessation treatment and follow-up with smoking cessation services both identified as important…
Celebrity-prompted awareness in vascular surgery
The vascular surgery field received a rare moment in the public spotlight recently as President Donald J. Trump was diagnosed with chronic venous insufficiency (CVI). The White House press secretary and appointed physician to the president even made statements on…
FDA grants approval for IDE study on Advance Evero 18 everolimus-coated balloon catheter
The Food and Drug Administration (FDA) has granted approval for Cook Medical to initiate an investigational device exemption (IDE) study on the Advance Evero 18 everolimus-coated percutaneous transluminal angioplasty (PTA) balloon catheter, the company reported today. The clinical study…